![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, September 02, 2020 6:45:37 PM
Biorestorative Therapies (BRTXQ) is a biotech company that is developing treatments for lower back pain and obesity/Diabetes/weight loss. The FDA has approved them to continue with phase two of their lumbar disc regeneration trial using stem cells. But, the company filed for bankruptcy 20 March 2020.
**I know, "this guy is an idiot." Let me see if I can change your mind in the next 2-3 minutes.**
WHAT YOU NEED TO KNOW:
1.) 20 March 2020 - Filed for bankruptcy
2.) April 2020 - John Desmarais (one of the best intellectual property lawyers in the U.S.) entered into a stalking horse agreement to buy the company. He would pay $500,000 to acquire the company, along with their assets (including their intellectual property). Once this came to fruition, the stock value hit bottom.
3.) Bankruptcy proceedings continued, the final hearing is in August. It was seeming as though the company would be purchased by Desmarais. THEN LAST MONTH, a large investment firm, AUCTUS Capital, threw a golden wrench into the bankruptcy process.
4.) AUCTUS has supplied money to Biorestorative to continue their business as usual. They have agreed to supply funding as well and hired their own lawyers to cancel the deal with Desmarais.
5.) Together, AUCTUS and BRTXQ have scrubbed their financials, cut the fat out of the budget and plan to begin their phase 2 trials and get BRTXQ back on the NASDAQ immediately after the bankruptcy proceedings. NOW, ON TO THE GOOD STUFF!
6.) BRTXQ's plan states that all equity holders will retain their equity (aka shares of common stock). No reverse splits, no issuing new stock that has to be traded for old stock. This is in part due to the fact that AUCTUS holds nearly $3 million in notes for BRTXQ, issuing new stock would wipe that money out. No one would want to see that happen, so this company has a HUGE investor fighting for it and the shareholders. This is in their plan, which is posted to their website under their Investors tab.
Why am I posting this? Because it has happened before..
American Axle & Manufacturing - 2009 low was .29, 2015 rose to $26
Concur - Low of .11 then rose to $129 for a 41,000% increase
General Growth Properties - Low of .31 to $25 to a 8,100% increase
I don't care if you buy, and this is no attempt to convince people to buy. I just wanted to throw it out there for others to see. These things do happen.
Last year the company was NASDAQ listed (delisted in March 2020 due to bankruptcy declaration) and had a yearly stock price range of .40-.80.
I have read the bankruptcy documents as they have been made public, and this company has had life brought back to it. If it works out, I hope it works out for all of us!
DISCLAIMER:
I currently hold positions in BRTXQ. This should not be taken as investment advice in any way. Just check things out for yourself and let me know what you think! - https://twitter.com/muladamus
Recent BRTX News
- BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(c)(1); Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 06/17/2024 11:05:00 AM
- Shares of Biotech MicroCap Rip on Licensing Talks • AllPennyStocks.com • 06/13/2024 03:40:00 PM
- BioRestorative Therapies in Substantive Discussions for Potential License Agreement for ThermoStem® Metabolic Disease Program • GlobeNewswire Inc. • 06/13/2024 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 06/11/2024 08:28:30 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 06/11/2024 08:23:50 PM
- BioRestorative Therapies, Inc. to attend the Jefferies 2024 Healthcare Conference • GlobeNewswire Inc. • 06/04/2024 12:50:00 PM
- BioRestorative Therapies Announces Receipt of Nasdaq Non-Compliance Notice • GlobeNewswire Inc. • 05/24/2024 11:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 08:51:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 08:45:27 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/16/2024 09:17:17 PM
- BioRestorative Therapies Provides First Quarter 2024 Business Update • GlobeNewswire Inc. • 05/14/2024 08:10:00 PM
- BioRestorative Therapies Enhances Preclinical Metabolic Program with a Novel Exosome-Based Biologic Targeting Obesity • GlobeNewswire Inc. • 05/08/2024 11:30:00 AM
- BioRestorative Therapies to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024 • GlobeNewswire Inc. • 04/30/2024 08:15:00 PM
- BioRestorative Therapies Announces Transformative Commercial Agreement with Cartessa, a Global Leader in Medical Aesthetics Technology • GlobeNewswire Inc. • 04/30/2024 11:30:00 AM
- Biotech Catches Major Premarket Bid Following FDA Clearance • AllPennyStocks.com • 04/16/2024 02:25:00 PM
- BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol Amendment • GlobeNewswire Inc. • 04/16/2024 11:45:00 AM
- BioRestorative Therapies Partners with Galen Patient Recruitment to Accelerate Completion of Enrollment in Phase 2 Trial of BRTX-100 in Chronic Lumbar Disc Disease • GlobeNewswire Inc. • 04/08/2024 11:45:00 AM
- BioRestorative Therapies Announces Filing of Form S-1 Registration Statement to Register for Resale Common Stock Underlying Previously Issued Warrants • GlobeNewswire Inc. • 04/03/2024 08:38:00 PM
- BioRestorative Therapies Announces Filing of 2023 Annual Report on Form 10-K • GlobeNewswire Inc. • 04/01/2024 11:45:00 AM
- BioRestorative Therapies to Participate in the 36th Annual ROTH Conference • GlobeNewswire Inc. • 03/11/2024 08:15:00 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/06/2024 09:34:22 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/15/2024 09:43:54 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/15/2024 09:40:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 09:27:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 09:25:23 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM